Roguin A (2011) Stent: the man and word behind the coronary metal prosthesis. Circ Cardiovasc Interv 4(2):206–209

Article  CAS  PubMed  Google Scholar 

Shah R, Rao SV, Latham SB, Kandzari DE (2018) Efficacy and safety of drug-eluting stents optimized for biocompatibility vs bare-metal stents with a single month of dual antiplatelet therapy: a meta-analysis. JAMA Cardiol 3(11):1050–1059

Article  PubMed  PubMed Central  Google Scholar 

Nicolas J, Pivato CA, Chiarito M et al (2022) Evolution of drug-eluting coronary stents: a back-and-forth journey from the bench-to-bedside. Cardiovasc Res 5:cvac105

Google Scholar 

Stefanini GG, Byrne RA, Windecker S, Kastrati A (2017) State of the art: coronary artery stents - past, present and future. EuroIntervention 13(6):706–716

Article  PubMed  Google Scholar 

Hassan S, Ali MN, Ghafoor B (2022) Evolutionary perspective of drug eluting stents: from thick polymer to polymer free approach. J Cardiothorac Surg 17(1):65

Article  PubMed  PubMed Central  Google Scholar 

Borhani S, Hassanajili S, Ahmadi Tafti SH, Rabbani S (2018) Cardiovascular stents: overview, evolution, and next generation. Prog Biomater 7(3):175–205

Article  CAS  PubMed  PubMed Central  Google Scholar 

Batchelor R, Dinh D, Brennan A et al (2020) VCOR investigators. Incidence, predictors and clinical outcomes of stent thrombosis following percutaneous coronary intervention in contemporary practice. Heart Lung Circ 29(10):1433–1439

Article  PubMed  Google Scholar 

Levine GN, Bates ER, Blankenship JC et al (2011) 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol 58:e44–e122

Article  PubMed  Google Scholar 

Khoso AA, Soomro GH, Mal SB et al (2022) Frequency, risk factors, and outcome of definite stent thrombosis: a single-center experience. Cureus 14(7):e27240

PubMed  PubMed Central  Google Scholar 

Iqbal J, Sumaya W, Tatman V et al (2013) Incidence and predictors of stent thrombosis: a single-centre study of 5,833 consecutive patients undergoing coronary artery stenting. EuroIntervention 9(1):62–69

Article  PubMed  Google Scholar 

Kereiakes DJ, Yeh RW, Massaro JM et al (2015) DAPT study investigators. Stent thrombosis in drug-eluting or bare-metal stents in patients receiving dual antiplatelet therapy. JACC Cardiovasc Interv 8(12):1552–1562

Article  PubMed  Google Scholar 

Bønaa KH, Mannsverk J, Wiseth R et al (2016) NORSTENT investigators. Drug-eluting or bare-metal stents for coronary artery disease. N Engl J Med 375(13):1242–1252

Article  PubMed  Google Scholar 

Yang YX, Liu Y, Li XW et al (2021) Clinical outcomes after percutaneous coronary intervention for early versus late and very late stent thrombosis: a systematic review and meta-analysis. J Thromb Thrombolysis 51(3):682–692

Article  PubMed  Google Scholar 

Raposeiras-Roubı´n S, Emad Abu-Assi E, Fabrizio D’Ascenzo F et al (2018) Annual incidence of confirmed stent thrombosis and clinical predictors in patients with ACS treated with ticagrelor or prasugrel. Rev Esp Cardiol 5

Armstrong EJ, Sab S, Singh GD et al (2014) Predictors and outcomes of recurrent stent thrombosis: results from a multicenter registry. J Am Coll Cardiol Intv 7:1105–1113

Article  Google Scholar 

Sudhir K, Hermiller JB, Ferguson JM, Simonton CA (2013) Risk factors for coronary drug-eluting stent thrombosis: influence of procedural, patient, lesion, and stent related factors and dual antiplatelet therapy. ISRN Cardiol 2013:748736

Article  PubMed  PubMed Central  Google Scholar 

Moukarbel GV (2022) Coronary stent thrombosis and mortality: Does the relationship stand the test of time? J Am Heart Assoc 11(7):e025341

Article  PubMed  PubMed Central  Google Scholar 

Secemsky EA, Matteau A, Yeh RW et al (2015) PROTECT trial investigators. Comparison of short- and long-term cardiac mortality in early versus late stent thrombosis (from Pooled PROTECT Trials). Am J Cardiol 115:1678–1684

Article  PubMed  Google Scholar 

Kumar R, Ammar A, Saghir T et al (2022) Incidence, predictors, and outcomes of acute and subacute stent thrombosis after emergency percutaneous coronary revascularization with drug-eluting stents: a prospective observational study. Glob Heart 17(1):24

Article  PubMed  PubMed Central  Google Scholar 

Gerhart A (2022) Outcomes and risk factors for stent thrombosis. J Thrombo Cir 8:199

Google Scholar 

CAPRIE Steering Committee (1996) A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348:1329–1339

Article  Google Scholar 

Hirsch J, Bhatt DL (2004) Comparative benefits of clopidogrel and aspirin in high-risk patient populations. Arch Intern Med 164:2106–2110

Article  Google Scholar 

(2001) The clopidogrel in unstable angina to prevent recurrent events trial investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345:494–502

Mehta SR, Yusuf S, Peters RJG et al (2001) Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 358:527–533

Article  CAS  PubMed  Google Scholar 

Steinhubl SR, Berger PB, Mann JT III et al (2002) For the CREDO Investigators. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 288:2411–2420

Article  CAS  PubMed  Google Scholar 

Sabatine MS, Cannon CP, Gibson CM et al (2005) The CLARITY-TIMI 28 investigators. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with STsegment elevation. N Engl J Med 352:1179–1189

Article  CAS  PubMed  Google Scholar 

Chen Z, Jiang L, Chen Y et al (2005) Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 366:1607–1621

Article  CAS  PubMed  Google Scholar 

Nso N, Nassar M, Zirkiyeva M et al (2022) Factors impacting stent thrombosis in patients with percutaneous coronary intervention and coronary stenting: a systematic review and meta-analysis. Cureus. 14(4):e23973

PubMed  PubMed Central  Google Scholar 

Condello F, Spaccarotella C, Sorrentino S et al (2023) Stent thrombosis and restenosis with contemporary drug-eluting stents: predictors and current evidence. J Clin Med 12(3):1238

Article  CAS  PubMed  PubMed Central  Google Scholar 

McLachlan AJ, Campbell TJ (2010) Variability in response to clopidogrel. Aust Prescr 33:62–63

Article  Google Scholar 

Harrison P, Frelinger AL, Furman MI, Michelson AD (2007) Measuring antiplatelet drug effects in the laboratory. Thromb Res 120:323–336

Article  CAS  PubMed  Google Scholar 

Gurbel Paul A, Tantry US (2007) Clopidogrel resistance? Thromb Res 120:311–321

Article  CAS  PubMed  Google Scholar 

Alrahbeni T (2021) New perspectives on clopidogrel resistance systematic review and meta-analysis. J Pharm Res Int 33:194–202

Article  Google Scholar 

Berenson AM, Hawken TN, Fort DG et al (2023) Clopidogrel resistance is common in patients undergoing vascular and coronary interventions. Vascular 31(1):58–63

Article  PubMed  Google Scholar 

Nguyen TA, Diodati JG, Pharand C (2005) Resistance to clopidogrel: a review of the evidence. J Am Coll Cardiol 45(8):1157–1164

Article  CAS  PubMed  Google Scholar 

Lawton JS, Tamis-Holland JE, Bangalore S et al (2022) 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: executive summary: a report of the american college of cardiology/American heart association joint committee on clinical practice guidelines. Circulation 145(3):e4–e17

PubMed  Google Scholar 

Liang B, Li R, Lu J, Tian XJ, Gu N (2022) Tongue diagnostic parameters-based diagnostic signature in coronary artery disease patients with clopidogrel resistance after percutaneous coronary intervention. Explore (NY) S1550–8307(22):00202–00206

Google Scholar 

Karabulut D, Kaya A, Abacı O et al (2021) The frequency of aspirin and clopidogrel resistance and related factors in patients undergoing elective percutaneous coronary intervention. EJCM 9(2):94–104

Article  Google Scholar 

Fontana P, Roffi M, Reny JL (2020) Platelet function test use for patients with coronary artery disease in the early 2020s. J Clin Med 9(1):194

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yao H, Ekou A, Niamkey T et al (2022) Acute coronary syndromes in sub-saharan africa: a 10-year systematic review. J Am Heart Assoc 11(1):e021107

Article  PubMed  Google Scholar